{"id":"W2986283446","doi":"10.25251/skin.3.supp.38","title":"Nail Outcome Improvements with Certolizumab Pegol in Moderate to Severe Plaque Psoriasis: Results from Phase 3 Trials","year":2019,"lang":"en","type":"article","venue":"SKIN The Journal of Cutaneous Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain","funders":"","keywords":"Certolizumab pegol; Medicine; Plaque psoriasis; Psoriasis; Nail (fastener); Dermatology; Outcome (game theory); Internal medicine; Infliximab; Tumor necrosis factor alpha; Materials science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016899,0.0006336204,0.001502165,0.0002109979,0.0002452495,0.0007604727,0.0003544723,0.0007920382,0.004826235],"category_scores_gemma":[0.001625239,0.0001615301,0.00185656,0.0002810192,0.0003782165,0.0004994203,0.0002007676,0.001830505,0.0005656888],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004451355,"about_ca_system_score_gemma":0.0004674967,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008117587,"about_ca_topic_score_gemma":0.001997605,"domain_scores_codex":[0.9995189,0.0002204382,0.00003398846,0.00006100968,0.00007840749,0.00008732369],"domain_scores_gemma":[0.9991241,0.0003927982,0.0001982086,0.00004767297,0.00008955192,0.0001476397],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5045062,0.006064697,0.004742987,0.01222479,0.00914214,0.0002068013,0.0001643475,0.001295287,0.01343781,0.0005146006,0.0164961,0.4312043],"study_design_scores_gemma":[0.7205676,0.1746321,0.06171346,0.003245484,0.01024537,0.000765346,0.0002365536,0.001432067,0.004586043,0.002215048,0.02028191,0.00007891638],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7530582,0.2183189,0.001711581,0.005067823,0.001118655,0.002538283,0.003301515,0.0003464929,0.01453863],"genre_scores_gemma":[0.9535778,0.03655476,0.001232086,0.003080611,0.0005352936,0.0008128764,0.001337673,0.00002783315,0.0028411],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004826235,"threshold_uncertainty_score":0.01614541,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03094004696178332,"score_gpt":0.2977013145001826,"score_spread":0.2667612675383993,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}